Neurobiology of Aging
Volume 27, Issue 7 , Pages 946-954 , July 2006

Deficient cerebral clearance of vasculotropic mutant Dutch/Iowa Double Aß in human AßPP transgenic mice

Received 22 February 2005 ,Revised 5 May 2005 ,Accepted 11 May 2005.

References 

  1. Borchelt DR, Thinakaran G, Eckman CB, Lee MK, Davenport F, Ratovitsky T, et al. Familial Alzheimer's disease-linked presenilin 1 variants elevate Abeta1–42/1–40 ratio in vitro and in vivo. Neuron. 1996;17:1005–1013
  2. Chartier-Harlin MC, Crawford F, Houlden H, Warren A, Hughes D, Fidani L, et al. Early-onset Alzheimer's disease caused by mutations at codon 717 of the beta-amyloid precursor protein gene. Nature. 1991;353:844–846
  3. Citron M, Oltersdorf T, Haass C, McConlogue L, Hung AY, Seubert P, et al. Mutation of the ß-amyloid precursor protein in familial Alzheimer's disease increases ß-protein production. Nature. 1992;360:672–674
  4. Davis J, Van Nostrand WE. Enhanced pathologic properties of Dutch-type mutant amyloid ß-protein. Proc Natl Acad Sci USA. 1996;93:2996–3000
  5. Davis J, Xu F, Deane R, Romanov G, Previti ML, Zeigler K, et al. Early-onset and robust cerebral microvascular accumulation of amyloid beta-protein in transgenic mice expressing low levels of a vasculotropic Dutch/Iowa mutant form of amyloid ß-protein precursor. J Biol Chem. 2004;279:20296–20306
  6. Deane R, Du Yan S, Submamaryan RK, LaRue B, Jovanovic S, Hogg E, et al. RAGE mediates amyloid beta-peptide transport across the blood–brain barrier and accumulation in brain. Nat Med. 2003;9:907–913
  7. Deane R, Wu Z, Sagare A, Davis J, Yan SD, Hamm K, et al. LRP-amyloid beta-peptide (Abeta) interaction regulates differential brain efflux of Abeta isoforms. Neuron. 2004;43:333–344
  8. DeMattos RB, O’dell MA, Parsadanian M, Taylor JW, Harmony JA, Bales KR, et al. Clusterin promotes amyloid plaque formation and is critical for neuritic toxicity in a mouse model of Alzheimer's disease. Proc Natl Acad Sci USA. 2002;99:10843–10848
  9. Ghersi-Egea JF, Gorevic PD, Ghiso J, Frangione B, Patlak CS, Fenstermacher JD. Fate of cerebrospinal fluid-borne amyloid beta-peptide: rapid clearance into blood and appreciable accumulation by cerebral arteries. J Neurochem. 1996;67:880–883
  10. Goate A, Chartier-Harlin MC, Mullan M, Brown J, Crawford F, Fidani L, et al. Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease. Nature. 1991;349:704–706
  11. Grabowski TJ, Cho HS, Vonsattel JPG, Rebeck GW, Greenberg SM. Novel amyloid precursor protein mutation in an Iowa family with dementia and severe cerebral amyloid angiopathy. Ann Neurol. 2001;49:697–705
  12. Hendriks L, van Duijn CM, Cras P, Cruts M, Van Hul W, van Harskamp F, et al. Presenile dementia and cerebral haemorrhage linked to a mutation at codon 692 of the beta-amyloid precursor protein gene. Nat Genet. 1992;1:218–221
  13. Jellinger KA. Alzheimer's disease and cerebrovascular pathology: an update. J Neural Transm. 2002;109:813–836
  14. Johnson-Wood K, Lee M, Motter R, Hu K, Gordon G, Barbour R, et al. Amyloid precursor protein processing and Aß42 deposition in a transgenic mouse model of Alzheimer's disease. Proc Natl Acad Sci USA. 1997;94:1550–1555
  15. Lemere CA, Lopera F, Kosik KS, Lendon CL, Ossa J, Saido TC, et al. The E280A presenilin 1 Alzheimer mutation produces increased A beta 42 deposition and severe cerebellar pathology. Nat Med. 1996;2:1146–1150
  16. Levy E, Carman MD, Fernandez-Madrid IJ, Power MD, Lieberburg I, van Duinen SG, et al. Mutation of the Alzheimer's disease amyloid gene in hereditary cerebral hemorrhage, Dutch type. Science. 1990;248:1124–1126
  17. Melchor JP, McVoy L, Van Nostrand WE. Charge alterations of E22 in the amyloid ß-protein enhance its pathogenic properties. J Neurochem. 2000;74:2209–2212
  18. Miravalle L, Tokuda T, Chiarle R, Giaccone G, Bugiani O, Tagliavini F, et al. Substitutions at codon 22 of Alzheimer's Aß peptide induce diverse conformational changes and apoptotic effects in human cerebral endothelial cells. J Biol Chem. 2000;275:27110–27116
  19. Monro OR, Mackic JB, Yamada S, Segal MB, Ghiso J, Maurer C, et al. Substitution at codon 22 reduces clearance of Alzheimer's amyloid-beta peptide from the cerebrospinal fluid and prevents its transport from the central nervous system into blood. Neurobiol Aging. 2002;23:405–412
  20. Morelli L, Llovera R, Gonzalez SA, Affranchino JL, Prelli F, Frangione B, et al. Differential degradation of amyloid beta genetic variants associated with hereditary dementia or stroke by insulin-degrading enzyme. J Biol Chem. 2003;278:23221–23226
  21. Mullan M, Crawford F, Axelman K, Houlden H, Lilius L, Winblad B, et al. A pathogenic mutation for probable Alzheimer's disease in the APP gene at the N-terminus of beta-amyloid. Nat Genet. 1992;1:345–347
  22. Rozemuller AJM, Roos RAC, Bots GTAM, Kamphorst W, Eikelenboom P, Van Nostrand WE. Distribution of beta/A4 and amyloid precursor protein in hereditary cerebral hemorrhage with amyloidosis-Dutch type and Alzheimer's disease. Am J Pathol. 1993;142:1449–1457
  23. Saporito-Irwin SM, Thinakaran G, Ruffini L, Sisodia SS, Van Nostrand WE. Amyloid ß-protein stimulates parallel increases in the cellular levels of its precursor and amyloid precursor-like protein 2 (APLP2) in human cerebrovascular smooth muscle cells. Amyloid. 1997;4:54–60
  24. Selkoe DJ. Alzheimer's disease: genes, proteins, and therapy. Physiol Rev. 2001;81:741–766
  25. Shibata M, Yamada S, Kumar SR, Calero M, Bading J, Frangione B, et al. Clearance of Alzheimer's amyloid-ß(1–40) peptide from brain by LDL receptor-related protein-1 at the blood–brain barrier. J Clin Invest. 2000;106:1489–1499
  26. Tagliavini F, Rossi G, Padovani A, Magoni M, Andora G, Sgarzi M, et al. A new BetaPP mutation related to hereditary cerebral haemorrhage. Alzheimer's Rep. 1999;2:S28
  27. Timmers WF, Tagliavini F, Haan J, Frangione B. Parenchymal preamyloid and amyloid deposits in the brains of patients with hereditary cerebral hemorrhage with amyloidosis–Dutch type. Neurosci Lett. 1990;118:223–226
  28. Tsubuki S, Takaki Y, Saido TC. Dutch Flemish, Italian, and Arctic mutations in APP and resistance of Abeta to physiologically relevant proteolytic degradation. Lancet. 2003;361:1957–1958
  29. Van Broeckhoven C, Haan J, Bakker E, Hardy JA, Van Hul W, Wehnert A, et al. Amyloid beta protein precursor gene and hereditary cerebral hemorrhage with amyloidosis (Dutch). Science. 1990;248:1120–1122
  30. van Duinen SG, Castano EM, Prelli F, Bots GTAM, Luyendijk W, Frangione B. Hereditary cerebral hemorrhage with amyloidosis in patients of Dutch origin is related to Alzheimer's disease. Proc Natl Acad Sci USA. 1987;84:5991–5994
  31. Van Nostrand WE, Wagner SL, Suzuki M, Choi BH, Farrow JS, Geddes JW, et al. Protease nexin-II, a potent antichymotrypsin, shows identity to the amyloid ß-protein precursor. Nature. 1989;341:546–549
  32. Van Nostrand WE, Melchor J, Ruffini L. Pathologic cell surface amyloid beta-protein fibril assembly in cultured human cerebrovascular smooth muscle cells. J Neurochem. 1997;69:216–223
  33. Van Nostrand WE, Melchor JP, Cho HS, Greenberg SM, Rebeck GW. Pathogenic Effects of D23N “Iowa” Amyloid ß-Protein. J Biol Chem. 2001;276:32860–32866
  34. Verbeek MM, de Waal RMW, Schipper JJ, Van Nostrand WE. Rapid degeneration of cultured human brain pericytes by amyloid beta protein. J Neurochem. 1997;68:1135–1141
  35. Vinters HV. Cerebral amyloid angiopathy: a critical review. Stroke. 1987;18:311–324
  36. Vinters HV, Farag ES. Amyloidosis of cerebral arteries. Adv Neurol. 2003;92:105–112
  37. Watson DJ, Selkoe DJ, Teplow DB. Effects of the amyloid precursor protein Glu693>Gln ‘Dutch’ mutation on the production and stability of amyloid beta-protein. Biochem J. 1999;340:703–709
  38. Wattendorff AR, Frangione B, Luyendijk W, Bots GTAM. Hereditary cerebral haemorrhage with amyloidosis, Dutch type (HCHWA-D): clinicopathological studies. J Neurol Neurosurg Psychiatry. 1995;59:699–705
  39. Weller RO, Massey A, Newman TA, Hutchings M, Kuo YM, Roher AE. Cerebral amyloid angiopathy: amyloid beta accumulates in putative interstitial fluid drainage pathways in Alzheimer's disease. Am J Pathol. 1998;153:725–733
  40. Weller RO, Massey A, Kuo YM, Roher AE. Cerebral amyloid angiopathy: accumulation of A beta in interstitial fluid drainage pathways in Alzheimer's disease. Ann NY Acad Sci. 2000;903:110–117
  41. Wisniewski T, Ghiso J, Frangione B. Peptides homologous to the amyloid protein of Alzheimer's disease containing a glutamine for glutamic acid substitution have accelerated amyloid fibril formation. Biochem Biophys Res Commun. 1991;179:1247–1254
  42. Yamamoto N, Hirabayashi Y, Amari M, Yamaguchi H, Romanov G, Van Nostrand WE, et al. Assembly of hereditary amyloid β-protein variants in the presence of favorable gangliosides. FEBS Lett. 2005;579:2185–2190

PII: S0197-4580(05)00188-0

doi: 10.1016/j.neurobiolaging.2005.05.031

Neurobiology of Aging
Volume 27, Issue 7 , Pages 946-954 , July 2006

Article Tools

* Image Usage & Resolution